LATEST NEWS
Dec 1, 2022
Cytox welcomes momentous and historic news for Alzheimer’s disease research – the dawn of a new therapeutic age?
Nov 21, 2022
First Choice Neurology tests first patients with the Alzheimer’s Risk Test
Meet the Team
Dr Richard Pither
CEO
Dr Alex Gibson
Business Development Officer
Dr Paula Daunt
Project and Portfolio Manager
Dr Qian Gao
Head of Bioinformatics and Genetics
Dr Simon Flint
Clinical Diagnostics Development Lead
Dr Amanda Bowden
Marketing and Commercial Operations Director
Dr Ian Gilham
Chairman
Dr David Whitcombe
Non-executive Director